Atlas Capital Advisors Inc. Makes New $63,000 Investment in Solventum Co. (NYSE:SOLV)

Atlas Capital Advisors Inc. bought a new stake in shares of Solventum Co. (NYSE:SOLV) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 950 shares of the company’s stock, valued at approximately $63,000.

A number of other hedge funds have also recently made changes to their positions in the stock. Modus Advisors LLC purchased a new position in Solventum during the fourth quarter valued at $25,000. Stonebridge Financial Group LLC bought a new position in shares of Solventum during the fourth quarter valued at $26,000. Crews Bank & Trust purchased a new position in shares of Solventum in the 4th quarter worth about $32,000. Synergy Asset Management LLC bought a new position in Solventum in the 4th quarter worth about $35,000. Finally, Spire Wealth Management purchased a new stake in Solventum during the 4th quarter valued at about $37,000.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on SOLV shares. Mizuho upped their target price on shares of Solventum from $70.00 to $82.00 and gave the stock a “neutral” rating in a research note on Monday, March 3rd. The Goldman Sachs Group increased their target price on Solventum from $63.00 to $71.00 and gave the company a “sell” rating in a research note on Monday, March 3rd. Bank of America boosted their price target on Solventum from $80.00 to $85.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 26th. Morgan Stanley increased their price objective on Solventum from $73.00 to $80.00 and gave the company an “equal weight” rating in a research report on Wednesday, March 5th. Finally, Wells Fargo & Company boosted their target price on Solventum from $73.00 to $75.00 and gave the stock an “equal weight” rating in a research report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, Solventum has an average rating of “Hold” and a consensus price target of $79.86.

Solventum Trading Down 5.7 %

Shares of NYSE:SOLV opened at $66.22 on Friday. Solventum Co. has a 52-week low of $47.16 and a 52-week high of $85.92. The stock has a market capitalization of $11.45 billion and a price-to-earnings ratio of 24.08. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. The stock’s 50-day simple moving average is $75.42 and its two-hundred day simple moving average is $71.95.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.